3N Bio is an innovative life science start-up that focuses on developing diagnostics to combat antimicrobial resistance (AMR). As a spin-off from SciLifeLab/Karolinska Institutet, our expertise lies in microbial metadegradomics, which allows us to enhance the efficiency, safety, and speed of developing small molecules that modulate the microbiome. Our cutting-edge technology offers immediate information on the impact of new drug substances on the microbiome.

Currently, our team is dedicated to applying this technology to measure cellular growth at the molecular level and expedite the diagnosis of phenotypic antimicrobial resistance. With the alarming rise of antibiotic-resistant bacteria and multidrug-resistant pathogenic fungi, 3N Bio is committed to providing fast and accurate diagnosis for bacterial infections. By detecting antimicrobial resistance independent of the drug resistance mechanism used, we aim to curtail the spread of AMR, ensure proper treatment for patients, and contribute to the individualized and rational use of antibiotics.

Located in Solna, Sweden, 3N Bio is at the forefront of tackling the global health threat posed by AMR. Contact us at info@3n-bio. com to learn more about how our mission can make a difference